Skip to main content
OpenTrials

Clinical trial condition

Ureteral Neoplasms

Explore clinical trials studying Ureteral Neoplasms. Study availability and eligibility vary by location and protocol.

63 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Ureteral Neoplasms trial results

Completed

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

NCT03219333

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
Locations
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
View all 81 locations
View Trial Details
Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details
Completed

Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma

NCT03513952

Conditions
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Carcinoma, +40 more
Locations
  • Kaiser Permanente-Riverside Riverside, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Straub Clinic and Hospital Honolulu, Hawaii, United States
  • University of Hawaii Cancer Center Honolulu, Hawaii, United States
View Trial Details
Completed

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

NCT01326871

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +20 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UF Health Center at Orlando Health Orlando, Florida, United States
  • Martin Health System Stuart, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

NCT02643043

Conditions
Bladder Cancer, Cancer of the Ureter, Carcinoma, +20 more
Locations
  • University of Southern Cailfornia Los Angeles, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Ichan School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

NCT03617913

Conditions
Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +24 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions